A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib
Clinical trial NCT06314919 · RECRUITING
Trial details
- NCT number
- NCT06314919
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-03-15
- Primary completion
- 2026-06-01
- Enrollment
- 8606
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.